Short-term, reading-to-reading ambulatory blood pressure (BP) variability appears to be associated with total and cardiovascular mortality among individuals with hypertension, according to data from the Spanish ABPM Registry.
Reducing low-density lipoprotein cholesterol (LDL-C) levels may cut the risk of atherosclerotic cardiovascular disease events in type 2 diabetes patients with metabolic dyslipidaemia, a recent study has shown.
Not only does taking antihypertensive drug at bedtime lead to better control of blood pressure (BP), it nearly halves the risk of cardiovascular events compared with dosing upon waking, according to the Hygia Chronotherapy Trial — thus debunking the long-held belief that antihypertensives should be taken in the morning.
Patients who have undergone revascularization for peripheral artery disease are at risk of earlier limb and later cardiovascular ischaemic events, and such risk is particularly greater among those with postprocedure major adverse limb events (MALE) hospitalization, according to a study.
Impaired endothelium-independent vascular smooth muscle reactivity negotiates the relationship between poor cognitive performance and high visceral adiposity in elderly adults with type 2 diabetes (T2D), according to a new Singapore study.
Several high-density lipoprotein (HDL) functionality parameters, which are linked to HDL roles on cholesterol metabolism, endothelial protection and antioxidant/anti-inflammatory defence, contribute to an increased risk of incident acute coronary syndromes and its manifestations in individuals at high risk of cardiovascular disease, a study reports.
A wearable arrhythmia detection device, the AliveCor KardiaBand (KB), demonstrates moderate accuracy for diagnosing atrial fibrillation (AF) in comparison with a 12-lead electrocardiogram (ECG), as shown in a recent study. However, combining the automated device diagnosis with the electrophysiologists (EP) interpretation of unclassified readings improves overall accuracy.